- call +1-201-465-4211
- email sales@mrinsights.biz
Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.
Scope of the Report:
This report focuses on the Medical Cannabis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The various economies are involved in the activities to legalize the export of medicinal cannabis product, which in turn is expected to fuel growth of the medical cannabis market.
The worldwide market for Medical Cannabis is expected to grow at a CAGR of roughly 23.9% over the next five years, will reach 12700 million US$ in 2023, from 3520 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Market Segment by Applications, can be divided into
Pain
Arthritis
Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Others
There are 15 Chapters to deeply display the global Medical Cannabis market.
Chapter 1, to describe Medical Cannabis Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Medical Cannabis, with sales, revenue, and price of Medical Cannabis, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Medical Cannabis, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Medical Cannabis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Medical Cannabis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Medical Cannabis Introduction
1.2 Market Analysis by Type
1.2.1 Tetrahydrocannabinol (THC)
1.2.2 Cannabidiol (CBD)
1.3 Market Analysis by Applications
1.3.1 Pain
1.3.2 Arthritis
1.3.3 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BOL Pharma
2.1.1 Business Overview
2.1.2 Medical Cannabis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BOL Pharma Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Tilray
2.2.1 Business Overview
2.2.2 Medical Cannabis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Tilray Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medreleaf Corporation
2.3.1 Business Overview
2.3.2 Medical Cannabis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medreleaf Corporation Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Aurora Cannabis, Inc
2.4.1 Business Overview
2.4.2 Medical Cannabis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Aurora Cannabis, Inc Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Canopy Growth Corporation
2.5.1 Business Overview
2.5.2 Medical Cannabis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Canopy Growth Corporation Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Insys Therapeutics, Inc
2.6.1 Business Overview
2.6.2 Medical Cannabis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Insys Therapeutics, Inc Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Aphria, Inc
2.7.1 Business Overview
2.7.2 Medical Cannabis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Aphria, Inc Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 MGC Pharmaceuticals Limited
2.8.1 Business Overview
2.8.2 Medical Cannabis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 GW Pharmaceuticals, plc
2.9.1 Business Overview
2.9.2 Medical Cannabis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Medical Marijuana Inc
2.10.1 Business Overview
2.10.2 Medical Cannabis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Medical Marijuana Inc Medical Cannabis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Medical Cannabis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Medical Cannabis Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Medical Cannabis Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Medical Cannabis Manufacturer Market Share in 2017
3.3.2 Top 6 Medical Cannabis Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Medical Cannabis Market Analysis by Regions
4.1 Global Medical Cannabis Sales, Revenue and Market Share by Regions
4.1.1 Global Medical Cannabis Sales and Market Share by Regions (2013-2018)
4.1.2 Global Medical Cannabis Revenue and Market Share by Regions (2013-2018)
4.2 North America Medical Cannabis Sales and Growth Rate (2013-2018)
4.3 Europe Medical Cannabis Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Medical Cannabis Sales and Growth Rate (2013-2018)
4.5 South America Medical Cannabis Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Medical Cannabis Sales and Growth Rate (2013-2018)
5 North America Medical Cannabis by Countries
5.1 North America Medical Cannabis Sales, Revenue and Market Share by Countries
5.1.1 North America Medical Cannabis Sales and Market Share by Countries (2013-2018)
5.1.2 North America Medical Cannabis Revenue and Market Share by Countries (2013-2018)
5.2 United States Medical Cannabis Sales and Growth Rate (2013-2018)
5.3 Canada Medical Cannabis Sales and Growth Rate (2013-2018)
5.4 Mexico Medical Cannabis Sales and Growth Rate (2013-2018)
6 Europe Medical Cannabis by Countries
6.1 Europe Medical Cannabis Sales, Revenue and Market Share by Countries
6.1.1 Europe Medical Cannabis Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Medical Cannabis Revenue and Market Share by Countries (2013-2018)
6.2 Germany Medical Cannabis Sales and Growth Rate (2013-2018)
6.3 UK Medical Cannabis Sales and Growth Rate (2013-2018)
6.4 France Medical Cannabis Sales and Growth Rate (2013-2018)
6.5 Russia Medical Cannabis Sales and Growth Rate (2013-2018)
6.6 Italy Medical Cannabis Sales and Growth Rate (2013-2018)
7 Asia-Pacific Medical Cannabis by Countries
7.1 Asia-Pacific Medical Cannabis Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Medical Cannabis Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Medical Cannabis Revenue and Market Share by Countries (2013-2018)
7.2 China Medical Cannabis Sales and Growth Rate (2013-2018)
7.3 Japan Medical Cannabis Sales and Growth Rate (2013-2018)
7.4 Korea Medical Cannabis Sales and Growth Rate (2013-2018)
7.5 India Medical Cannabis Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Medical Cannabis Sales and Growth Rate (2013-2018)
8 South America Medical Cannabis by Countries
8.1 South America Medical Cannabis Sales, Revenue and Market Share by Countries
8.1.1 South America Medical Cannabis Sales and Market Share by Countries (2013-2018)
8.1.2 South America Medical Cannabis Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Medical Cannabis Sales and Growth Rate (2013-2018)
8.3 Argentina Medical Cannabis Sales and Growth Rate (2013-2018)
8.4 Colombia Medical Cannabis Sales and Growth Rate (2013-2018)
9 Middle East and Africa Medical Cannabis by Countries
9.1 Middle East and Africa Medical Cannabis Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Medical Cannabis Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Medical Cannabis Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Medical Cannabis Sales and Growth Rate (2013-2018)
9.3 UAE Medical Cannabis Sales and Growth Rate (2013-2018)
9.4 Egypt Medical Cannabis Sales and Growth Rate (2013-2018)
9.5 Nigeria Medical Cannabis Sales and Growth Rate (2013-2018)
9.6 South Africa Medical Cannabis Sales and Growth Rate (2013-2018)
10 Global Medical Cannabis Market Segment by Type
10.1 Global Medical Cannabis Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Medical Cannabis Sales and Market Share by Type (2013-2018)
10.1.2 Global Medical Cannabis Revenue and Market Share by Type (2013-2018)
10.2 Tetrahydrocannabinol (THC) Sales Growth and Price
10.2.1 Global Tetrahydrocannabinol (THC) Sales Growth (2013-2018)
10.2.2 Global Tetrahydrocannabinol (THC) Price (2013-2018)
10.3 Cannabidiol (CBD) Sales Growth and Price
10.3.1 Global Cannabidiol (CBD) Sales Growth (2013-2018)
10.3.2 Global Cannabidiol (CBD) Price (2013-2018)
11 Global Medical Cannabis Market Segment by Application
11.1 Global Medical Cannabis Sales Market Share by Application (2013-2018)
11.2 Pain Sales Growth (2013-2018)
11.3 Arthritis Sales Growth (2013-2018)
11.4 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications) Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Medical Cannabis Market Forecast (2018-2023)
12.1 Global Medical Cannabis Sales, Revenue and Growth Rate (2018-2023)
12.2 Medical Cannabis Market Forecast by Regions (2018-2023)
12.2.1 North America Medical Cannabis Market Forecast (2018-2023)
12.2.2 Europe Medical Cannabis Market Forecast (2018-2023)
12.2.3 Asia-Pacific Medical Cannabis Market Forecast (2018-2023)
12.2.4 South America Medical Cannabis Market Forecast (2018-2023)
12.2.5 Middle East and Africa Medical Cannabis Market Forecast (2018-2023)
12.3 Medical Cannabis Market Forecast by Type (2018-2023)
12.3.1 Global Medical Cannabis Sales Forecast by Type (2018-2023)
12.3.2 Global Medical Cannabis Market Share Forecast by Type (2018-2023)
12.4 Medical Cannabis Market Forecast by Application (2018-2023)
12.4.1 Global Medical Cannabis Sales Forecast by Application (2018-2023)
12.4.2 Global Medical Cannabis Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Medical Cannabis Picture
Table Product Specifications of Medical Cannabis
Figure Global Sales Market Share of Medical Cannabis by Types in 2017
Table Me
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
